Equine Sports Council

Controlled Medications Library

ESC MEDICATION CLASSIFICATIONClass A - Therapeutic

ESC Medication Library · Revision 2

← Medication library · Compare sanctioning bodies

Medication Facts

Performance enhancing
No
Total hours to clear
0
Frequently used
N/A
ESC ID
MISOPR-0589
Trade names
Cytotec
Drug type
Prostaglandin analog
Plasma half-life · hours
Not Published
Equine dosing
5 mcg/kg PO
Cmax · peak plasma concentration
Unavailable
Tmax · time to peak plasma concentration
N/A
ESC concentration guidance
May not exceed 6% efficacy in plasma
Primary withdrawal · hours
0
Washout withdrawal · hours
0
ESC control type
A1 - Generally Controlled - Therapeutic
Medication report required
Generally not required, however understand exceptions.

Uses & side effects

Treatment of ulcers

Product-specific side effects await source review.

Drug interactions

Misoprostol (Cytotec®) is an FDA-approved drug used in humans to prevent or treat gastric ulcers caused by NSAIDs. [2]

In horses, it is used off-label to prevent NSAID-induced hindgut issues such as colitis or hindgut ulcers. In addition, it can be used to treat gastric ulcers in the stomach’s glandular region.

Misoprostol is a synthetic prostaglandin E1 analogue that acts as a cytoprotectant, protecting cells from damage. [9] This drug can reduce inflammation in the gut and help ease some of the associated discomforts.

It has been shown to reduce the secretion of gastric acid in the stomach of horses. [13] Excessive acidity contributes to the formation of ulcers by eroding cells that line the intestinal tract.

Misoprostol has also been shown to improve intestinal barrier function in the gut of horses on NSAID medications. It helps to support the healing of the gastrointestinal mucosa following injury. [32]

Effects of NSAIDs
Pain-relieving NSAID medications – such as flunixin meglumine (banamine), and phenylbutazone (bute) – inhibit the enzyme cyclooxygenase-1 (COX-1). This enzyme is involved in pathways that activate inflammation following injury or infections.

In particular, the COX-1 enzymes make molecules called prostaglandins and thromboxane, which are involved in activating the immune system and causing a pain response.

Blocking COX-1 with NSAIDs is an effective way to relieve pain, inflammation and fever, which is why these drugs are commonly prescribed for horses with colic, arthritis or laminitis. Long-term use of NSAIDs may be required to provide comfort and improve the quality of life for these horses.

Prostaglandins and Gut Health
However, prostaglandins are also important for protecting cells of the digestive tract. The digestive tract is lined with a mucous barrier known as the mucosa. This blocks bacteria and toxins from being absorbed while allowing nutrients to pass into the blood.

Prostaglandins are involved in maintaining this defensive mucosal barrier and have several effects on the digestive tract, including: [3][4][5][6]

Increase blood flow in the mucosa by causing blood vessels to dilate
Raise mucosal bicarbonate secretion which helps to neutralize stomach acid
Decrease stomach acid production
Modulate immune responses
NSAIDs and Gut Injury
By blocking COX-1, NSAIDs suppress prostaglandin production, which compromises the mucosa’s ability to form a protective barrier between the environment inside the digestive tract and the cells lining it.

This allows stomach acidity and other irritants to cause inflammation, ulcers and bleeding throughout the gut.

In addition, NSAIDs will slow the recovery of pre-existing lesions by causing neutrophils to gather at the injury and exacerbate inflammation. [7][8]

COX-2-specific NSAIDs such as Equioxx and Previcox have been developed to lessen the digestive side effects of NSAID use. However, their long-term use may still induce injury in the small and large intestines. [31]

Ideally NSAIDs should be avoided in horses with pre-existing ulcers in the gastrointestinal tract. However, these horses may develop conditions such as laminitis which require treatment with NSAIDs. Misoprostol may be administered concurrently with the NSAIDs to help prevent ulcers from worsening. [7]7) Marshall, J. F. et al. The effect of

Contraindications

Sanctioning-body comparison

Plasma only. Compare published competition guidance for this medication. ESC guidance remains in Medication Facts above. A dosing guideline, withdrawal recommendation and laboratory detection threshold are different measures.

Sources reviewed September 23, 2026. “Not verified” means a gap in this comparison, not zero tolerance or permission. Doses describe the cited rules; your veterinarian must determine treatment and withdrawal.

Published guidance by organization
OrganizationPublished dose & routePlasma concentrationWithdrawal / timingControl / penalty class
AQHA Show HorsesShow rules · 2026 handbook
Conditions & sources

An unverified entry is not permission to use this medication. Consult the linked current rules.

Reviewed 2026-09-23

Not verified for this medication.Not verified for this medication.Not verified for this medication.Medication-specific control not yet verified.
APHA Paint Show HorsesShow rules · 2026 Rule Book
Conditions & sources

An unverified entry is not permission to use this medication. Consult the linked current rules.

Reviewed 2026-09-23

Not verified for this medication.Not verified for this medication.Not verified for this medication.Medication-specific control not yet verified.
ARCI Model RulesRacing model · Rules 15 / UCG 20.0 / CTMS 4.2.1
Conditions & sources

An unverified entry is not permission to use this medication. Consult the linked current rules. ARCI model comparison only; no state-specific rule is substituted. Schedule timing is tied to its stated regimen and is not a clearance guarantee.

UCG 20.0 PDF p. 40

Reviewed 2026-09-23

Not verified for this medication.Not verified for this medication.Not verified for this medication.Drug Class 5 · Penalty Class D. No dosing permission is implied by classification.
USEFNational Therapeutic Substance Provisions · 2026 + July amendment
Conditions & sources

An unverified entry is not permission to use this medication. Consult the linked current rules.

Reviewed 2026-09-23

Not verified for this medication.Not verified for this medication.Not verified for this medication.Medication-specific control not yet verified.